Dendritic Cell Control of Intestinal T Cell Responses
树突状细胞控制肠道 T 细胞反应
基本信息
- 批准号:8868105
- 负责人:
- 金额:$ 37.19万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-07-05 至 2016-06-30
- 项目状态:已结题
- 来源:
- 关键词:Antigen-Presenting CellsAntigensAutoimmune DiseasesAutoimmunityBiochemicalCD4 Positive T LymphocytesCell CommunicationCell Differentiation processCellsCellular biologyChronicColitisComplexDataDendritic CellsDendritic cell activationDevelopmentDietDiseaseEquilibriumGenerationsGoalsHelper-Inducer T-LymphocyteHumanIL17 geneImmune ToleranceImmune responseImmune systemImmunityInfectionInflammationInflammatoryInflammatory Bowel DiseasesInflammatory disease of the intestineIntegrinsInterferon Type IIIntestinesKnockout MiceLicensingLinkMaintenanceMediatingMolecularMusMyeloid CellsPathologyPeptide HydrolasesPhenotypePlayPopulationPreventionPrimary Cell CulturesProcessProductionPropertyPublishingReactionRegulationRegulatory T-LymphocyteRoleSignal TransductionSurfaceT cell responseT-LymphocyteTestingTh1 CellsTransforming Growth Factor betaTranslatingWorkbasecommensal microbescytokinein vivoinnovationinterleukin-23intestinal epitheliummicroorganismmucosal sitepathogenpreventresponse
项目摘要
DESCRIPTION (provided by applicant): Mucosal surfaces such as the intestinal epithelium provide a complex challenge to the immune system, as they must maintain effective immunity against potential pathogen attack while also tolerating commensal microorganisms and dietary antigens. The balance between tolerance and immunity is mediated in large part by the specialized T cell populations, regulatory T cells (Tregs) and Th17 cells. Disruption of the balance between these subsets has been heavily implicated in causing colitis through studies in both mice and humans. Furthermore, Th17 cells are emerging as contributors to many other inflammatory and autoimmune disorders. Understanding how Th17 responses are initiated and regulated is therefore critical to our understanding of both intestinal immunity and chronic inflammatory disease. Our long term goal is to understand how Dendritic Cells (DCs) and other antigen presenting cells initiate and maintain the correct balance of T-helper cell subsets. The objective in this application is to establish how DCs regulate T cell responses to TGF-ß and control Th17 cell differentiation. The rationale for this work is that understanding this process has the potential to translate into new therapies for Th17-mediated diseases. Our central hypothesis is that DC expression of αvß8 and subsequent activation of TGF-ß controls induction and maintenance of Th17 responses. Based on published work and preliminary data, this hypothesis will be tested in three specific aims: (1) Determine how αv integrins expressed by DCs regulate Th17 cell differentiation, particularly the generation of IL17/ IFN-γ-expressing cells
associated with autoimmunity. Conditional knockout mice will be used to study the role for αv integrins in vivo, and results will be extended to humans though primary cell culture. (2) Understand how ß8 expression is regulated in DCs during homeostatic regulation and following infection. (3) Determine the mechanisms by which αvß8 function is regulated on DCs using cell biology and biochemical approaches. This approach is innovative as it focuses on the role of DCs in 'licensing' T cell responses to
TGF-ß. The proposed work is significant because it will provide a much needed understanding of how DCs promote the initiation of Th17 cells in the intestine and regulate their subsequent differentiation in response to environmental and infectious challenges.
描述(由应用提供):粘膜表面(例如肠上皮)为免疫系统提供了复杂的挑战,因为它们必须维持对潜在病原体攻击的有效免疫组织化学,同时还可以耐受共生微生物和饮食抗原。耐受性和免疫组织化学之间的平衡在很大程度上是由专业的T细胞群,调节性T细胞(Treg)和TH17细胞介导的。这些子集之间平衡的破坏已经很大程度上涉及通过对小鼠和人类的研究引起结肠炎。此外,TH17细胞正在成为许多其他炎症和自身免疫性疾病的贡献者。因此,了解如何启动和调节Th17反应对于我们对肠道免疫学和慢性炎症性疾病的理解至关重要。我们的长期目标是了解树突状细胞(DC)和其他抗原呈递细胞如何启动并维持T-辅助细胞亚群的正确平衡。该应用程序的目的是确定DCS如何调节T细胞对TGF-ß的反应并控制Th17细胞分化。这项工作的理由是,了解这一过程有可能转化为Th17介导的疾病的新疗法。我们的中心假设是αVß8的直流表达以及随后的TGF-β控制TH17响应的诱导和维持。根据已发表的工作和初步数据,该假设将以三个特定的目的进行检验:(1)确定DC表达的αV整合素如何调节Th17细胞分化,尤其是IL17/ IFN-γ的细胞的产生
与自身免疫相关。有条件的敲除小鼠将用于研究体内αV整联蛋白的作用,结果将通过原代细胞培养扩展到人类。 (2)了解在稳态调节和感染后,在DC中如何调节ß8表达。 (3)确定使用细胞生物学和生化方法在DC上调节αVß8功能的机制。这种方法具有创新性,因为它侧重于DC在“许可” T细胞响应中的作用
TGF-ß。拟议的工作很重要,因为它将非常需要了解DC如何促进肠道中Th17细胞的主动性,并根据环境和感染性挑战来调节其随后的分化。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Integrin αv in the mechanical response of osteoblast lineage cells.
- DOI:10.1016/j.bbrc.2014.04.006
- 发表时间:2014-05-02
- 期刊:
- 影响因子:3.1
- 作者:Kaneko, Keiko;Ito, Masako;Naoe, Yoshinori;Lacy-Hulbert, Adam;Ikeda, Kyoji
- 通讯作者:Ikeda, Kyoji
αv Integrins regulate germinal center B cell responses through noncanonical autophagy.
αv 整合素通过非典型自噬调节生发中心 B 细胞反应。
- DOI:10.1172/jci99597
- 发表时间:2018
- 期刊:
- 影响因子:0
- 作者:Raso,Fiona;Sagadiev,Sara;Du,Samuel;Gage,Emily;Arkatkar,Tanvi;Metzler,Genita;Stuart,LyndaM;Orr,MarkT;Rawlings,DavidJ;Jackson,ShaunW;Lacy-Hulbert,Adam;Acharya,Mridu
- 通讯作者:Acharya,Mridu
β8 Integrin Expression and Activation of TGF-β by Intestinal Dendritic Cells Are Determined by Both Tissue Microenvironment and Cell Lineage.
- DOI:10.4049/jimmunol.1600244
- 发表时间:2016-09-01
- 期刊:
- 影响因子:0
- 作者:Boucard-Jourdin M;Kugler D;Endale Ahanda ML;This S;De Calisto J;Zhang A;Mora JR;Stuart LM;Savill J;Lacy-Hulbert A;Paidassi H
- 通讯作者:Paidassi H
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Adam Lacy-Hulbert其他文献
Adam Lacy-Hulbert的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Adam Lacy-Hulbert', 18)}}的其他基金
LITAF regulation of cell death and inflammatory responses
LITAF 调节细胞死亡和炎症反应
- 批准号:
10886166 - 财政年份:2023
- 资助金额:
$ 37.19万 - 项目类别:
Immune Signatures and Clinical Outcomes in Acute Pancreatitis
急性胰腺炎的免疫特征和临床结果
- 批准号:
10568011 - 财政年份:2023
- 资助金额:
$ 37.19万 - 项目类别:
alpha v integrin regulation of B cell tolerance
B 细胞耐受的 α v 整合素调节
- 批准号:
10294130 - 财政年份:2020
- 资助金额:
$ 37.19万 - 项目类别:
Identification of Host Drug Development Targets in Influenza Using Transposon Mutagenesis
使用转座子诱变鉴定流感宿主药物开发靶点
- 批准号:
8956296 - 财政年份:2015
- 资助金额:
$ 37.19万 - 项目类别:
Identification of Host Drug Development Targets in Influenza Using Transposon Mutagenesis
使用转座子诱变鉴定流感宿主药物开发靶点
- 批准号:
9089858 - 财政年份:2015
- 资助金额:
$ 37.19万 - 项目类别:
Transposon Mutagenesis for Host-Target and Drug Discovery in Infectious Disease
传染病宿主靶标和药物发现的转座子诱变
- 批准号:
8883359 - 财政年份:2014
- 资助金额:
$ 37.19万 - 项目类别:
Transposon Mutagenesis for Host-Target and Drug Discovery in Infectious Disease
传染病宿主靶标和药物发现的转座子诱变
- 批准号:
8490300 - 财政年份:2012
- 资助金额:
$ 37.19万 - 项目类别:
Dendritic Cell Control of Intestinal T Cell Responses
树突状细胞控制肠道 T 细胞反应
- 批准号:
8372489 - 财政年份:2012
- 资助金额:
$ 37.19万 - 项目类别:
Transposon Mutagenesis for Host-Target and Drug Discovery in Infectious Disease
传染病宿主靶标和药物发现的转座子诱变
- 批准号:
8391403 - 财政年份:2012
- 资助金额:
$ 37.19万 - 项目类别:
Dendritic Cell Control of Intestinal T Cell Responses
树突状细胞控制肠道 T 细胞反应
- 批准号:
8843114 - 财政年份:2012
- 资助金额:
$ 37.19万 - 项目类别:
相似国自然基金
基于表达MHC-肽嵌合抗原受体T细胞治疗自身免疫疾病的策略和机制研究
- 批准号:81901643
- 批准年份:2019
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
滤泡辅助性T细胞在CTLA-4Ig诱导Graves病免疫耐受中的作用及机制研究
- 批准号:81801621
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
白塞氏病新自身抗原筛选和分子分型研究
- 批准号:81571592
- 批准年份:2015
- 资助金额:50.0 万元
- 项目类别:面上项目
基于疾病易感性的SSA抗原肽诱导原发干燥综合征模型的建立及模型机制的研究
- 批准号:81571593
- 批准年份:2015
- 资助金额:95.0 万元
- 项目类别:面上项目
抗原提呈细胞分化发育功能调控及参与炎症性自身免疫性疾病的表观遗传机制研究
- 批准号:81230074
- 批准年份:2012
- 资助金额:270.0 万元
- 项目类别:重点项目
相似海外基金
Tolerance-Inducing mRNA Nanoparticles to Treat Type 1 Diabetes
诱导耐受的 mRNA 纳米颗粒治疗 1 型糖尿病
- 批准号:
10835326 - 财政年份:2023
- 资助金额:
$ 37.19万 - 项目类别:
A modular cell therapy platform for controlling immunological tolerance
用于控制免疫耐受的模块化细胞治疗平台
- 批准号:
10725007 - 财政年份:2023
- 资助金额:
$ 37.19万 - 项目类别:
Aire-dependent thymic B-1a cells play a key role in neonatal tolerance induction
Aire 依赖性胸腺 B-1a 细胞在新生儿耐受诱导中发挥关键作用
- 批准号:
10660882 - 财政年份:2023
- 资助金额:
$ 37.19万 - 项目类别:
Democratizing CAR T cell therapy by in situ programming of virus-specific T cells
通过病毒特异性 T 细胞的原位编程使 CAR T 细胞疗法大众化
- 批准号:
10739646 - 财政年份:2023
- 资助金额:
$ 37.19万 - 项目类别:
Strategies to attenuate the indirect alloimmune response in encapsulated pancreatic islet transplantation
减弱封装胰岛移植中间接同种免疫反应的策略
- 批准号:
10678425 - 财政年份:2023
- 资助金额:
$ 37.19万 - 项目类别: